Despesa De Juros Sobre A Dívida Alterar Data
AstraZeneca USD 340M 144M 2026-06
Genmab DKK 139M 129M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Qiagen NV USD 10.02M 1.03M 2026-06
UCB EUR 49M 29M 2025-12